Invitrogen™ SARS Coronavirus Spike Protein Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA141142

Catalog No. 01-675-720

Description

The immunogen is 69%(11/16) homologous to SARS-COV-2 (COVID-19) Spike protein. The cross reactivity is not empirically tested. Suggested positive control: transfected mouse melanoma cell lysate.

It has recently been shown that SARS (severe acute respiratory syndrome) is caused by a human coronavirus. Human coronaviruses are the major cause of upper respiratory tract illness, such as the common cold, in humans. Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb). The first step in coronavirus infection is binding of the viral spike protein, a 139-kDa protein, to certain receptors on host cells. The spike protein is the main surface antigen of the coronavirus. The glycosylated spike protein (as well as the nucleocapsid protein) can be detected in infected cell culture supernatants with antisera from SARS patients.

Specifications

• Antigen: SARS Coronavirus Spike Protein
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene Alias: Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2
• Immunogen: Synthetic peptide corresponding to resikdues 288-303 of the putative SARS Spike glycoprotein.
• Quantity: 100 μg
• Primary or Secondary: Primary
• Content And Storage: -20°C or -80°C if preferred
• Form: Liquid

• Applications: ELISA, In vitro Assay, Western Blot
• Concentration: 1.0 mg/mL
• Formulation: PBS with 0.2% gelatin and 0.05% sodium azide
• Host Species: Rabbit
• Purification Method: Protein G
• Regulatory Status: RUO
• Target Species: Virus
• Product Type: Antibody
• Isotype: IgG